- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x F9Q: 6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 8 residues within 4Å:- Chain A: F.71, A.81, A.82, G.85, F.88, I.89
- Ligands: OLC.28, OLC.29
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.71, A:A.81, A:F.88, A:I.89
- Hydrogen bonds: A:A.82
- Water bridges: A:Q.172, A:Q.172
CLR.4: 9 residues within 4Å:- Chain A: L.349, L.352, P.353, I.357, C.367, S.368, A.370, L.374
- Ligands: OLA.7
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.349, A:L.352, A:P.353, A:I.357, A:L.374
- Hydrogen bonds: A:S.368
CLR.5: 7 residues within 4Å:- Chain A: L.196, C.359, F.360, F.363, C.364
- Ligands: OLA.20, OLC.23
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.196, A:F.360, A:F.360, A:F.360, A:F.363
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.6: 7 residues within 4Å:- Chain A: P.70, T.74, T.77, F.79
- Ligands: OLA.13, OLC.26, OLC.28
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:P.70, A:T.74, A:T.77
- Hydrogen bonds: A:T.77
OLA.7: 3 residues within 4Å:- Chain A: W.373, L.377
- Ligands: CLR.4
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.373, A:L.377
OLA.8: 4 residues within 4Å:- Chain A: I.342, G.345, L.346
- Ligands: OLA.20
No protein-ligand interaction detected (PLIP)OLA.9: 6 residues within 4Å:- Chain A: F.53, A.106, I.109, D.110, V.125, I.133
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.106, A:I.109, A:I.133
OLA.10: 4 residues within 4Å:- Chain A: I.25, T.384, V.388, F.391
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.25, A:T.384, A:V.388
OLA.11: 7 residues within 4Å:- Chain A: G.14, V.17, V.21, W.373, Y.376, V.380
- Ligands: OLA.15
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:V.17, A:V.21, A:W.373, A:Y.376, A:Y.376, A:V.380
- Water bridges: A:W.373
OLA.12: 3 residues within 4Å:- Chain A: I.136
- Ligands: OLA.17, OLC.22
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.136
OLA.13: 3 residues within 4Å:- Ligands: OLA.6, OLA.18, OLC.26
No protein-ligand interaction detected (PLIP)OLA.14: 7 residues within 4Å:- Chain A: L.28, L.31, G.32, L.35, W.38, V.387, F.391
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.35, A:V.387, A:F.391, A:F.391
OLA.15: 2 residues within 4Å:- Chain A: W.373
- Ligands: OLA.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.373, A:W.373
OLA.16: 5 residues within 4Å:- Chain A: I.12, S.16, I.19, T.20
- Ligands: OLA.18
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.20
OLA.17: 4 residues within 4Å:- Chain A: R.129, G.132, V.139
- Ligands: OLA.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.139
OLA.18: 7 residues within 4Å:- Chain A: I.12, S.15, I.19, L.23, T.77
- Ligands: OLA.13, OLA.16
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.19, A:L.23, A:T.77
- Hydrogen bonds: A:S.15
OLA.19: 5 residues within 4Å:- Chain A: V.34, C.37, W.38, W.41
- Ligands: OLC.30
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.34, A:W.41
- Hydrogen bonds: A:W.41
OLA.20: 8 residues within 4Å:- Chain A: L.199, L.203, Y.206, A.341, A.344, G.345
- Ligands: CLR.5, OLA.8
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.203
- 10 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLC.21: 5 residues within 4Å:- Chain A: Y.188, F.192, L.200, F.363
- Ligands: OLC.23
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.200
- Hydrogen bonds: A:Y.188
OLC.22: 8 residues within 4Å:- Chain A: H.84, A.143, M.149, L.150, G.151, N.153
- Ligands: OLA.12, OLC.27
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.143, A:L.150
- Hydrogen bonds: A:N.153, A:N.153
- Salt bridges: A:H.84
OLC.23: 4 residues within 4Å:- Chain A: L.196, F.363
- Ligands: CLR.5, OLC.21
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.196, A:F.363
- Water bridges: A:F.363
OLC.24: 2 residues within 4Å:- Ligands: OLC.29, OLC.30
No protein-ligand interaction detected (PLIP)OLC.25: 5 residues within 4Å:- Chain A: A.82, C.83, H.84, G.85, G.171
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:H.84
- Hydrogen bonds: A:C.83, A:H.84, A:G.85
- Water bridges: A:E.170, A:G.171
OLC.26: 3 residues within 4Å:- Ligands: OLA.6, OLA.13, OLC.28
No protein-ligand interaction detected (PLIP)OLC.27: 7 residues within 4Å:- Chain A: W.138, F.142, A.143, L.146, M.149
- Ligands: OLC.22, OLC.29
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.138, A:F.142, A:F.142, A:F.142, A:L.146
- Water bridges: A:M.149
OLC.28: 11 residues within 4Å:- Chain A: V.66, L.67, P.70, F.71, T.74, F.79, C.80, Q.172
- Ligands: CLR.3, OLA.6, OLC.26
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.67, A:P.70, A:F.71, A:T.74, A:F.79, A:F.79
- Hydrogen bonds: A:C.80, A:Q.172
- Water bridges: A:C.80
OLC.29: 12 residues within 4Å:- Chain A: Y.52, A.59, L.63, L.67, F.92, G.127, I.134, W.138
- Ligands: CLR.3, OLC.24, OLC.27, OLC.30
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.59, A:L.63, A:L.67, A:F.92, A:W.138
- Hydrogen bonds: A:G.127
OLC.30: 9 residues within 4Å:- Chain A: C.37, W.41, Y.52, V.55, A.59, L.63
- Ligands: OLA.19, OLC.24, OLC.29
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.55, A:A.59, A:L.63
- Hydrogen bonds: A:Y.52
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Borodovsky, A. et al., Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity. J Immunother Cancer (2020)
- Release Date
- 2019-06-26
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x F9Q: 6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 10 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Borodovsky, A. et al., Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity. J Immunother Cancer (2020)
- Release Date
- 2019-06-26
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.